IMMUNOME INC

About

Immunome Inc. is a clinical-stage biotechnology company focused on discovering and developing targeted immuno-oncology therapies to treat cancer. The company utilizes its proprietary discovery platform to leverage the human immune memory, identifying antibodies derived from patients who have successfully mounted an immune response against their tumors. By applying this approach, Immunome aims to build a pipeline of novel treatments designed to address complex and difficult-to-treat malignancies.